In oncology, change doesn’t wait.
Clinical trial data evolves by the hour, guidelines shift rapidly, and regulatory approvals are updated in real time. For practicing oncologists seeing 20–30 patients a day, staying “up to date” often feels like an impossible task. Traditional tools simply weren’t built for the speed or complexity of modern cancer care.
As Dr. Sarkisian shares in his recent discussion, the challenge isn’t just access to information, it’s access to the right information, when it matters. Sifting through endless trial abstracts, publications, and guidelines leaves little room for practical, real-time decision-making. And the cost of delay isn’t theoretical, it impacts lives.
That’s where Oncoscope-AI comes in.
By combining the speed of AI with the clinical judgment of expert human reviewers, Oncoscope-AI filters, organizes, and prioritizes the most relevant oncology data daily. It’s not just another search tool or chatbot. It’s a decision support platform purpose-built to meet oncologists where they are: at the point of care, under pressure, and in need of trusted, clinically aligned information.
In less than three clicks, physicians can access:
- Real-time summaries of trial data
- Links to original publications
- Cross-referenced insights from ASCO, PubMed, NCCN, and FDA approvals
- Evidence tailored to patient characteristics
Physicians know, real-time decisions demand real-time data; anything less puts patients at risk.
Beka Vinogradov is the Digital Communications Lead for Oncoscope-AI. She holds a Master’s in Health Administration and has extensive experience and education in business, marketing, and design.
